MAPK1 and lung carcinoma: Attenuation of ERK/c-Myc axis in lung cancer resulted in reduced expression of proteins involved in G1-S progression and led to G1 phase arrest.171 In particular, targeting PI3K/AKT/mTOR pathway seems to be more effective.